Pfizer and Biontech submitted a request to the Food and Drug Administration for their updated COVID booster shots for ...
Younger children could soon be eligible to receive an updated Covid-19 booster shot. Pfizer and BioNTech on Monday said they ...
The submission comes after Moderna requested emergency use authorization for its updated booster for 6-17 year olds.
Pfizer and German partner BioNTech said Monday they're seeking Food and Drug Administration authorization for their ...
Most children ages 5-11 have not gotten the original COVID-19 vaccine, which would make them illegible for the updated shot.
Vaccine manufacturers Pfizer-BioNTech and Moderna have asked the U.S. Food and Drug Administration to authorize their omicron ...
Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to ...
Pfizer and BioNTech announced Monday that they had submitted a request for Emergency Use from the U.S. Food and Drug Administration for vaccine booster doses tailored to the omicron variant of ...
Pfizer-BioNTech submitted an application for the FDA to authorize its BA.4/BA.5 bivalent COVID-19 vaccine for kids 5 to 11 at ...
The request, if cleared, would make U.S. kids between 5 through 11 eligible to receive a "bivalent" shot targeting components ...
The two pharma companies said a request for a vaccine marketing application will be submitted to the European Medicines ...
The 10-milligram booster dose is designed to combat the BA.4 and BA.5 strains of COVID-19 that currently cause the most cases ...